tirzepatide medication names FDA Grants a New Indication for Obesity Management GLP-1 Medications for Weight Loss:

ICV injection of the dual GLP-1/GIP receptor agonist reduces the doses of GLP-1 and GIP, activates hypothalamic neurons (c-fos), and increases anorectic POMC gene expression, while treatment with the same dose of GLP-1 and GIP alone does not achieve these results

Patients are encouraged to increase physical activity gradually

If nausea persists or is accompanied by other concerning symptoms such as severe abdominal pain or fever, its essential to seek medical attention promptly, as this could indicate a more serious reaction to the medication

Understanding Semaglutide and Tirzepatide Semaglutide and Tirzepatide are both medications originally designed for the treatment of type 2 diabetes, but they have also shown remarkable effectiveness in promoting weight loss

Insulin resistance causes Doctors aren't sure exactly why people develop insulin resistance